These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 581034

  • 1. Experimental anti-arrhythmic properties of melperone, a neuroleptic butyrophenone.
    Petersen EN.
    Acta Pharmacol Toxicol (Copenh); 1978 May; 42(5):388-94. PubMed ID: 581034
    [Abstract] [Full Text] [Related]

  • 2. A comparison of the experimental anti-arrhythmic properties of acebutolol (M and B 17,803), propranolol and practolol.
    Basil B, Jordan R, Loveless AH, Maxwell DR.
    Br J Pharmacol; 1974 Mar; 50(3):323-33. PubMed ID: 4850183
    [Abstract] [Full Text] [Related]

  • 3. [Experimental anti-arrhythmic effects of a new beta-adrenergic receptor blocking agent, dl-l-(tert. butylamino)-3-[(2-propinyloxy)phenoxy]2-propanol hydrochloride (dl Kö 1400-Cl)].
    Matsubara I, Hashimoto K, Katano Y, Tsukada T, Matsuda H.
    Nihon Yakurigaku Zasshi; 1976 Jul; 72(5):557-71. PubMed ID: 11153
    [Abstract] [Full Text] [Related]

  • 4. Experimental evaluation of antiarrhythmic drugs in the guinea pig.
    Giudicelli JF, Witchitz S, Larno S, Boissier JR.
    Biomedicine; 1973 Jul 20; 19(7):308-13. PubMed ID: 4783987
    [No Abstract] [Full Text] [Related]

  • 5. Observations on models used for the evaluation of antiarrhythmic drugs.
    Baum T, Eckfeld DK, Shropshire AT, Rowles G, Varner LL.
    Arch Int Pharmacodyn Ther; 1971 Sep 20; 193(1):149-70. PubMed ID: 5111320
    [No Abstract] [Full Text] [Related]

  • 6. The reversal of experimental cardiac arrhythmias by indoramin (Wy 21901).
    Alps BJ, Hill M, Fidler K, Johnson ES, Wilson AB.
    J Pharm Pharmacol; 1971 Sep 20; 23(9):678-86. PubMed ID: 4398246
    [No Abstract] [Full Text] [Related]

  • 7. Effects of adrenergic beta-blockers and a membrane stabilizing agent on ouabain-induced cardiac arrhythmias in anaesthetized guinea pigs.
    Aberg G, Adler G, Duker G, Ek B, Telemo E.
    Acta Pharmacol Toxicol (Copenh); 1979 Aug 20; 45(2):102-6. PubMed ID: 40389
    [Abstract] [Full Text] [Related]

  • 8. Antiarrhythmic effects of a novel diamine derivative, AN-132, on several animal models of cardiac arrhythmias.
    Sakai K, Yamazaki T, Takagi M.
    Tohoku J Exp Med; 1987 Apr 20; 151(4):443-51. PubMed ID: 3617055
    [Abstract] [Full Text] [Related]

  • 9. Anti-arrhythmic effect of nadolol in experimental arrhythmias: comparison with propranolol and alprenolol.
    Nakashima M, Takiguchi Y, Oguro K, Sogabe K, Hashimoto H.
    J Pharmacobiodyn; 1985 Jan 20; 8(1):1-10. PubMed ID: 4009395
    [Abstract] [Full Text] [Related]

  • 10. [Brevikarin dihydrochloride--a new original anti-arrhythmia agent].
    Denisenko PP, Vinogradova TV, Semenov AA.
    Farmakol Toksikol; 1988 Jan 20; 51(2):50-3. PubMed ID: 3378605
    [Abstract] [Full Text] [Related]

  • 11. Antiarrhythmic activity of dextro- and levo-isomers of 5-methyl-8-(2-hydroxy-3-t-butylamino-propoxy) coumarin hydrocholoride (bucumolol), a beta-adrenergic blocking agent, on aconitine-induced atrial and ouabain-induced ventricular arrhythmias in dogs.
    Nakayama K, Oshima T, Koike H.
    Jpn J Pharmacol; 1979 Dec 20; 29(6):935-45. PubMed ID: 44326
    [Abstract] [Full Text] [Related]

  • 12. Antiarrhythmic properties of a neuroleptic butyrophenone, melperone, in acute myocardial infarction. A double-blind trial.
    Møgelvang JC, Petersen EN, Folke PE, Ovesen L.
    Acta Med Scand; 1980 Dec 20; 208(1-2):61-4. PubMed ID: 7435249
    [Abstract] [Full Text] [Related]

  • 13. Antiarrhythmic effect of aprindine on several types of ventricular arrhythmias.
    Ueda M, Kimoto S, Matsuda S, Kawakami M, Mroishige E, Matsumura S, Takeda H.
    Jpn J Pharmacol; 1975 Oct 20; 25(5):549-61. PubMed ID: 1221137
    [Abstract] [Full Text] [Related]

  • 14. The clinical pharmacology and therapeutic applications of the antiarrhythmic drugs.
    Mason DT, Spann JF, Zelis R, Amsterdam EA.
    Clin Pharmacol Ther; 1970 Oct 20; 11(4):460-80. PubMed ID: 4913865
    [No Abstract] [Full Text] [Related]

  • 15. [Effects of 6,7-dimethoxycoumarin on experimental arrhythmia].
    Du GY, Ye WH, Lü F, Jing HD.
    Zhongguo Yao Li Xue Bao; 1993 Nov 20; 14 Suppl():S16-8. PubMed ID: 8010065
    [Abstract] [Full Text] [Related]

  • 16. Antiarrhythmic properties of 5-(3-tert-butylamino-2-hydroxy)propoxy-3,4-dihydrocarbostyril hydrochloride (OPC-1085), a newly synthesized, potent beta-adrenoreceptor antagonist.
    Yabuuchi Y, Hashimoto K, Yamashita S, Uno T, Shintani S, Nakagiri N.
    Clin Exp Pharmacol Physiol; 1977 Nov 20; 4(6):545-59. PubMed ID: 22416
    [Abstract] [Full Text] [Related]

  • 17. Antiarrhythmic and hemodynamic effects of prifuroline.
    Benharkate M, Plassard G, Legeai J, Worcel M.
    Arzneimittelforschung; 1986 Dec 20; 36(12):1761-7. PubMed ID: 3566836
    [Abstract] [Full Text] [Related]

  • 18. Studies on a new 1,5-benzothiazepine derivative (CRD-401). V. Antiarrhythmic actions.
    Yamada K, Shimamura T, Nakajima H.
    Jpn J Pharmacol; 1973 Jun 20; 23(3):321-8. PubMed ID: 4146776
    [No Abstract] [Full Text] [Related]

  • 19. Drug therapy for cardiac arrhythmias.
    Chung EK.
    Postgrad Med; 1973 Apr 20; 53(5):107-14. PubMed ID: 4701893
    [No Abstract] [Full Text] [Related]

  • 20. Cardiac arrhythmias in the elderly: antiarrhythmic drug treatment.
    Nestico PF, Morganroth J.
    Cardiol Clin; 1986 May 20; 4(2):285-303. PubMed ID: 3085932
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.